Denosumab Is Superior to Raloxifene in Lowering Risks of Mortality and Ischemic Stroke in Osteoporotic Women

• Main Authors: Ting-Chun Liu (Author), Chien-Ning Hsu (Author), Wen-Chin Lee (Author), Shih-Wei Wang (Author), Chiang-Chi Huang (Author), Yueh-Ting Lee (Author), Chung-Ming Fu (Author), Jin-Bor Chen (Author), Lung-Chih Li (Author)
• Format: Book
• Published: MDPI AG, 2023-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Both osteoporosis and cardiovascular disease (CVD) share similar pathways in pathophysiology and are intercorrelated with increased morbidity and mortality in elderly women. Although denosumab and raloxifene are the current guideline-based pharmacological treatments, their impacts on cardiovascular...